Overview

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Status:
Completed

Trial end date:
2003-10-01

Target enrollment:

Participant gender:

Summary

Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.

Phase:

Phase 4

Details

Lead Sponsor:

Sanofi

Treatments:

Glimepiride